Patents 2018-12-04T01:47:21+00:00

Selected Patents

1 9,989,519 Method for determining in vitro bioequivalence of a sucralfate suspension sample to a sucralfate suspension reference listed drug (RLD)
2 9,913,884 HLA-A2 tumor associated antigen peptides and compositions
3 9,744,175 Compositions of combinations of non-covalent DNA binding agents and anti-cancer and/or anti-inflammatory agents and their use in disease treatment
4 9,394,350 HLA-A2 tumor associated antigen peptides and compositions
5 9,382,376 Use of polymer D-lactic acid (PDLA) or equivalents thereof to inhibit growth of cancer cells and diagnose cancers
6 9,283,272 Targeting intracellular target-binding determinants with intracellular antibodies
7 9,168,275 Method of treating gastrointestinal diseases associated with species of genus Clostridium
8 9,119,832 Methods of treating mild brain injury
9 8,999,349 HMGB1-derived peptides enhance immune response to antigens
10 8,969,077 Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord
11 8,920,789 Use of polymer D-lactic acid (PDLA) or equivalents thereof to inhibit growth of cancer cells and diagnose cancers
12 8,883,502 Expandable cell source of neuronal stem cell populations and methods for obtaining and using them
13 8,709,421 Combination of the application of antibodies for immunostimulation together with glucocorticoids
14 8,586,307 Methods for diagnosing epigenetic, transgenerational effects of environmental toxicants on mammalian germ-lines and treating associated diseases
15 8,377,474 Controlled release formulations of levodopa and uses thereof
16 8,263,068 Modified cells expressing a protein that modulates activity of bHLH proteins, and uses thereof
17 8,241,863 Identification of an evolutionarily conserved pathway mediating transrepression of inflammatory response genes by nuclear receptors
18 8,207,292 Treatment of COPD, gastro-esophageal reflux disease (GERD), food allergies and other gastrointestinal conditions and disorders ameliorated by proper histamine management using a combination of histidine decarboxylase inhibitors, LRA drugs, anti-H1 and/or anti-H2 drugs
19 8,207,188 Treatment of diseases modulated by a H4 receptor agonist
20 8,058,395 Chimeric protein comprising a green fluorescent ptotein fused to a transcription factor
21 8,007,827 Pharmaceutical dosage forms having immediate release and/or controlled release properties
22 7,972,798 Method for identifying diabetic patients at increased risk for pathological complications
23 7,893,217 Isolated human antibodies that bind epitopes on RG1
24 7,887,804 Methods for treating disease-states associated with RG1 using immunoconjugates
25 7,311,910 Methods for treating cancer and infectious disease by blocking CTLA4-B7interactions